Figure 1.
Orphan drug approval classified by therapeutic indication. The pie graph indicates the orphan drug approvals granted by the FDA between the years of 1983 and 2009. “Other” includes respiratory, intoxication, immunologic, psychiatric, musculoskeletal, gastrointestinal, dermatologic, ophthalmologic, hepatic/biliary, cardiovascular, and genitourinary indications.